Grace Therapeutics (GRCE) Goodwill (2022 - 2026)
Grace Therapeutics (GRCE) posted Goodwill of $8.1 million for Q1 2026, little changed sequentially from $8.1 million in Q4 2025, and little changed YoY from $8.1 million in Q1 2025.
Grace Therapeutics (GRCE) Goodwill (2022 - 2026) Analysis & Trends
Grace Therapeutics has reported Goodwill for 5 years, with the latest figure at $8.1 million in Q1 2026.
- Quarterly Goodwill changed 0.0% year-over-year to $8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.1 million (changed 0.0% YoY) and the FY2026 annual result came in at $8.1 million, changed 0.0% from the prior year.
- Goodwill held at $8.1 million in Q1 2026 per GRCE's latest filing, from $8.1 million in the prior quarter.
- Over five years, Goodwill peaked at $13.0 million in Q1 2022 and troughed at $8.1 million in Q1 2023.
- A 5-year average of $9.3 million and a median of $8.1 million in 2023 frame the typical range for Goodwill.
- The sharpest annual moves came in 2023 and 2024: Goodwill plunged 37.23% in 2023, then changed 0.0% in 2024.
- Over 5 years, Goodwill stood at $13.0 million in 2022, then sank by 37.23% to $8.1 million in 2023, then changed by 0.0% to $8.1 million in 2024, then changed by 0.0% to $8.1 million in 2025, then changed by 0.0% to $8.1 million in 2026.
- According to Business Quant data, Goodwill over the past three periods registered $8.1 million, $8.1 million, and $8.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Grace Therapeutics | 37.99 Mn | 37.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.14 Mn |
| Mar 31, 2026 | 8.14 Mn |
| Dec 31, 2025 | 8.14 Mn |
| Sep 30, 2025 | 8.14 Mn |
| Jun 30, 2025 | 8.14 Mn |
| Mar 31, 2025 | 8.14 Mn |
| Dec 31, 2024 | 8.14 Mn |
| Sep 30, 2024 | 8.14 Mn |
| Jun 30, 2024 | 8.14 Mn |
| Mar 31, 2024 | 8.14 Mn |
| Dec 31, 2023 | 8.14 Mn |
| Sep 30, 2023 | 8.14 Mn |
| Jun 30, 2023 | 8.14 Mn |
| Mar 31, 2023 | 8.14 Mn |
| Dec 31, 2022 | 12.96 Mn |
| Sep 30, 2022 | 12.96 Mn |
| Jun 30, 2022 | 12.96 Mn |
| Mar 31, 2022 | 12.96 Mn |